• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER, INC. (IRWINDALE) NAVISTAR® THERMOCOOL®; SIMILAR DEVICE NI75TCJH, PMA # P030031

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER, INC. (IRWINDALE) NAVISTAR® THERMOCOOL®; SIMILAR DEVICE NI75TCJH, PMA # P030031 Back to Search Results
Model Number D-1197-00
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Embolism (1498); Thrombosis (2100)
Event Date 12/31/2013
Event Type  Injury  
Manufacturer Narrative
No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the no lot number was provided by the customer.Since the lot number is unknown, the full udi number cannot be provided.Concomitant products that were used during this study: carto; acunav 8f 64-element phased-array intracardiac echocardiography catheter.Other company¿s devices that were used during this study: bard transvenous 6f quadripolar catheter; boston scientific bi-directional closed irrigated ablation catheter (b)(4).The device was not returned.
 
Event Description
This complaint is from a literature source.It was reported that two patients underwent radiofrequency catheter ablation for ventricular tachycardia (vt) and suffered post-procedural deep vein thrombosis with pulmonary embolism requiring anticoagulant therapy.After these two thrombotic events, intravenous heparin therapy was routinely used for 48 hours after all pericardial drains were removed.Title: "long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy" the purpose of this study was to determine the long-term outcomes of vt control and need for anti-arrhythmic drug therapy after endocardial and adjuvant epicardial substrate modification in patients with arrhythmogenic right ventricular cardiomyopathy.Suspected device is navistar thermocool ablation catheter.Concomitant products that were used during this study: carto; acunav 8f 64-element phased-array intracardiac echocardiography catheter.Other company's devices that were used during this study: bard transvenous 6f quadripolar catheter; boston scientific bi-directional closed irrigated ablation catheter.The awareness date for this complaint is 4/14/2016 because the article was reviewed on 4/14/2016.
 
Manufacturer Narrative
Additional information was received from author on june 07 2016: the cause of reported deep venous thrombosis complications were related to long procedure.One of the two patients who suffered deep venous thrombosis was required inferior vena cava filter.Both patients were anticoagulated.All patients were required extended hospitalization and fully recovered.All patients had arrhythmogenic right ventricular cardiomyopathy and recurrent drug refractory ventricular tachycardia.The event did not result in the impairment of a body function or damage to a body structure.All complications were recognized risks associated with the vt ablation procedure.No complication was related to thermocool catheter.Patient demographic information: female, (b)(6); female, (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAVISTAR® THERMOCOOL®
Type of Device
SIMILAR DEVICE NI75TCJH, PMA # P030031
Manufacturer (Section D)
BIOSENSE WEBSTER, INC. (IRWINDALE)
15715 arrow highway
irwindale CA 91706
Manufacturer (Section G)
BIOSENSE WEBSTER, INC. (IRWINDALE)
15715 arrow highway
irwindale CA 91706
Manufacturer Contact
joaquin kurz
33 technology drive
irvine, CA 92618
9497893837
MDR Report Key5632934
MDR Text Key44452520
Report Number2029046-2016-00041
Device Sequence Number1
Product Code OAD
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/15/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/04/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD-1197-00
Device Catalogue NumberD119700
Device Lot NumberUNKNOWN_NAVISTAR THERMO TC
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received04/14/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age51 YR
Patient Weight66
-
-